MVA Oncology Network meeting

    Welcome to MVA Oncology Network and our 8th meeting!
    Clinical development: Challenges, opportunities & what can we learn from each other?

    Finding the right treatment for the right patient is a major challenge within oncology R&D. The clinical transition phase is a crucial step and several aspects need to be considered for successful clinical trials.

    Medicon Valley Alliance, together with one of our members – Clinical Studies Sweden – Forum South – welcomes you to the MVA Oncology Network and our 8th meeting where we will discuss clinical development. The meeting format will include presentations and a discussion forum where challenges, opportunities and lessons learned will be highlighted. Various stakeholders relevant for clinical development will be at place and look forward to discussing this topic with you.

    Date: 23 September, 2019
    Time: 17:00 – 20:00
    Clinical Studies Sweden – Forum South, Region Skåne
    Venue: Medicon Village, Auditorium, Scheelevägen 2, 223 63 Lund
    Cost: Free of charge for MVA members

    Sign up

    Do you have any specific question/challenge/aspect within clinical development that you wish to be discussed during the meeting? Please contact Senior Project Manager Helen Pettersson: no later than 13th September.

    The network
    MVA Oncology Network is a professional and social network for professors, PI and corporate level executives from the regional oncology eco-system. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region.

    Joining the network is free of charge and is limited to Medicon Valley Alliance members only. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the oncology network.


    Moderator: Petter Hartman, CEO, Medicon Valley Alliance

    17:00-17:30  Registration, networking and a bite to eat – meet the fellow participants
    17:30-17:35  Welcome 
    Petter Hartman, CEO, Medicon Valley Alliance
    Ulf Malmqvist, Director, Clinical Studies Sweden – Forum South
    17:35-17:40  Clinical trials and patent lifecycle optimization

    Peter Holm, Partner, European Patent Attorney, HØIBERG

    “Who are we?” 5 x 5 minute corporate/academic presentations
    Pitches from MVA Oncology Network organizations

    Johanna Mercke Odeberg, Head of Clincal Trial Unit and Clinical Support, Clinical Studies Sweden- Forum South

    Björn Ohlsson, Medical Adviser, Regionalt Cancercentrum (RCC) Syd

    Maureen Deehan – Head of Corporate Development & Strategy, Nordic Nanovector GmbH, Switzerland 

    Petra Hamerlik, Associate Professor, University of Copenhagen

    Ana Carneiro, Senior Consultant, Oncology Clinical Trials Unit, Department of Oncology, Hematology and Radiation Physics, Skane University Hospital


    Presentation of clinical development /research projects by various stakeholders: 8 minute presentations


    Marianne Pilgaard, CEO, Trial Nation Denmark Lars Thorsson, VP Clinical Development, Cantargia AB
    Repurposing cationic amphiphilic drugs for cancer treatment
    Marja Jäättelä, Professor, Danish Cancer Society
    Majken Westergaard, VP, Head of Clinical Operations, Genmab


    18:50-19:30 Clinical development and research: Challenges, opportunities & what can we learn from each other?
    Discussion forum based on experienced challenges/ opportunities as well as questions raised by network members

    Moderator: Lisa Rydén, Professor of Surgery, Lund University & Senior Consultant, Skåne University Hospital

    19:30 Concluding remarks
    Ulf Malmqvist, Director, Clinical Studies Sweden – Forum South
    19:30-20:00 Networking and refreshments

    Host and sponsor Sponsors


    MVA Oncology Network is managed by In collaboration with